News
Russian antitumor drugs first time received a registration certificate in Europe
Two BIOCAD products, Acellbia and Herticad , received the first European registration certificate in Bosnia and Herzegovina. Registration was received with the support of ICM d.o.o partner and is valid for 5 years. The first deliveries shall start in...
News
UK designs portable coronavirus testing kit that gives results in 50 minutes
Researchers in the UK have designed a portable smartphone-based coronavirus testing kit which they say can provide results for COVD-19 in just 50 minutes after taking a throat swab.
Most current tests take 24-48 hours to provide results because they...
News
CPhI announces new pharma events calendar for 2020
The CPhI Pharma portfolio confirms new exhibition dates for CPhI Japan, CPhI South East Asia and CPhI North America. Following a detailed review of attendee requirements and event feasibility, the organizers have moved quickly to secure new dates for...
News
Turkish Cargo uses passenger aircrafts of Turkish Airlines for Medical cargo
Turkish Cargo started to operate cargo flights with Turkish Airlines’ passenger aircrafts in addition to its 25 high capacity freighters in order to prevent any mishaps in the supply chain of medical cargo of vital importance.
Flying the first of...
News
Quidel’s Lyra SARS-CoV-2 Assay Receives Authorization for Expanded Use for Molecular Detection of COVID-19
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel’s Lyra® SARS-CoV-2 Assay has received expanded Emergency Use Authorization (EUA) claims from the Food and Drug Administration (FDA)...
News
MIG USA, a North Carolina Company, to Bring Needed Relief Through the Provision of Coronavirus Test Kits
MIG USA, LLC , a High Point, North Carolina company having focus in the biotechnology, pharmaceutical, and clinical research sectors, along with its corporate partner, have acquired the exclusive rights to manufacture and distribute a rapid-result coronavirus test kit,...
News
Pfizer Wins New Pediatric Approval for Atopic Dermatitis Ointment Eucrisa
The U.S. FDA greenlit a new pediatric approval for Pfizer’s Eucrisa ointment in the treatment of mild-to-moderate atopic dermatitis, an inflammatory skin disease that impacts a large number of pre-adolescent children.
Pfizer announced late Monday that the FDA approved a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















